Search Results for "Brian Groves Pfizer Bio"

22:40 EDT 26th July 2017 | BioPortfolio

Matching Channels

CTLA4 Mab rDNA Pfizer

Insulin rDNA inhaled Pfizer

Lymphocyte Immune Globulin Pfizer

Somatropin Hgh rDNA Pfizer

What is GENOTROPIN? GENOTROPIN (somatropin [rDNA origin] for injection) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference i...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

Pfizer, Sangamo team to develop Hemophilia A gene therapy programs

Brian BerkUnder the terms of the collaboration agreement, Sangamo will receive a $70 million upfront payment from Pfizer. read more

Pfizer Announces First Partners of Pfizer Healthcare Hub: London

Pfizer Ltd has announced that Echo, Cera and GiveVision will form the first cohort of healthtech start-ups to be supported by the Pfizer Healthcare Hub: London.The three start-ups will work with Pfi...

Pfizer’s Progress on 2020 Waste Reduction Goals

SOURCE: Pfizer DESCRIPTION:In alignment with the global sustainable development goals, Pfizer has committed to reduce its total hazardous and non-hazardous waste disposal by 15 percent by 2020.  Lear...

New board members named by AtriCure

Regina Groves, CEO of REVA Medical, and B.  -More- 

Pfizer beats 1Q profit forecasts

In this Monday, Nov. 23, 2015, file photo, flags fly in front of Pfizer World Headquarters, in New York. Pfizer Inc. reports earnings, Tuesday, May 2, 2017.

Former Pfizer R&D President Joins Frequency Therapeutics

NewsLaMattina previously was president of Pfizer global R&D and senior vice president of Pfizer, Inc. During his tenure, Pfizer discovered and developed Tarceva, Chantix, Zoloft (PTSD), Selzentry and ...

Pfizer-Aktie moderat im Minus

Anteilseigner von Pfizer verzeichnen gegenwärtig einen Kursabschlag im Depot: Der Kursverlust beträgt -0,4% im Vergleich zum Vortages-Schlusskurs. Damit entwickelt sich Pfizer schlechter als der D...

Aurobindo’s hypertension and diabetes generics earn FDA approval

Brian BerkThe Food and Drug Administration has approved Aurobindo’s generic of Daiichi Sankyo’s Azor and its generic of Pfizer’s Glucotrol XL.   read more

Matching PubMed Articles

First person: Brian Druker, MD.

Is a SIMPLe smartphone application capable of improving biological rhythms in bipolar disorder?

Biological rhythms (BR) disturbance has been suggested as a potential mediator of mood episodes in Bipolar Disorder (BD). The Biological Rhythms Interview of Assessment in Neuropsychiatry (BRIAN) was ...

In Memoriam: Brian T. Collins, M.D.

Pfizer drops phase 3 lipid-lowering antibody.

Special Issue of New Biotechnology in Memory of Professor Brian F.C. Clark (1936-2014).

Search Whole site using Google

Quick Search
Advertisement Advertisement